HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of metastatic retinoblastoma.

AbstractPURPOSE:
The risk for death in patients with retinoblastoma is increased in those who present with metastatic disease, and the role of intensive chemotherapy and autologous hematopoietic stem cell rescue in these patients remains unclear.
DESIGN:
Nonrandomized interventional case series.
PARTICIPANTS:
Four consecutive patients with metastatic retinoblastoma.
METHODS:
We treated four patients with retinoblastoma metastatic to the bone and bone marrow with intensive chemotherapy, consolidation with megatherapy, and autologous hematopoietic stem cell rescue. Chemotherapy included courses of carboplatin and etoposide alternating with cyclophosphamide, etoposide, and either carboplatin or cisplatin. Radiation therapy was delivered to areas of bone metastases.
MAIN OUTCOME MEASURES:
Patient survival.
RESULTS:
All patients completed and responded to the scheduled therapy; complete response of the bone marrow disease was documented after two courses of chemotherapy in all cases. Two patients are long-term survivors.
CONCLUSIONS:
The treatment described has been successful in obtaining disease-free survival in patients with metastatic retinoblastoma.
AuthorsCarlos Rodriguez-Galindo, Matthew W Wilson, Barrett G Haik, Mindy J Lipson, Alvida Cain, Thomas E Merchant, Sue Kaste, Charles B Pratt
JournalOphthalmology (Ophthalmology) Vol. 110 Issue 6 Pg. 1237-40 (Jun 2003) ISSN: 0161-6420 [Print] United States
PMID12799253 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bone Marrow Neoplasms (mortality, secondary, therapy)
  • Bone Neoplasms (mortality, secondary, therapy)
  • Child, Preschool
  • Disease-Free Survival
  • Eye Enucleation
  • Eye Neoplasms (mortality, pathology, therapy)
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Infant
  • Male
  • Radiotherapy, Adjuvant
  • Retinoblastoma (mortality, secondary, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: